It has been an honor and privilege to serve as Editor-in-Chief of Pigment Cell & Melanoma Research. This is a unique journal in many respects. It is the official journal of two scientific societies. Established first as Pigment Cell Research under the auspices of the Federation of Pigment Cell Societies, later became Pigment Cell & Melanoma Research by welcoming Society for Melanoma Research to be equal partner. With this merger, the scope of manuscripts now published span the widest range of topics that include chemistry of melanin, vertebrate pigmentation, and pigmentary diseases to melanoma biology and clinical trials. I enjoyed the front row view of this expansive landscape and made every effort to make each issue reflect the scope of the journal.

I have many individuals to thank for making it a worthwhile journey. Foremost, the Associate Editors, who often shouldered equal burden, colleagues, who stepped up every time they were asked to review manuscripts, and the journal staff at Wiley, who supported the workflow. I will miss the opportunity and the privilege of being the first to glimpse research coming out from laboratories across the world. I will miss the opportunity to read the insightful reviews from researchers I hold in high esteem.

Six years ago, when I accepted to serve as Editor-in-Chief of this journal, there was some unspoken skepticism about the viability of the journal in its current form in the fast-changing landscape of journal publishing. As an optimist, I brushed aside such skepticism. Even after 6 years in the trenches, including the difficult period of COVID-19 pandemic, I remain optimistic about the future of this unique journal. There are and will be many challenges to overcome. A journal is only as good as the quality of manuscripts it receives and the peer reviews of those manuscripts. Therefore, it is my sincere hope that the members of the pigment cell and melanoma community, bound together by our interest in this fascinating entity we call “melanocyte”, choose this journal as their first choice to submit and publish their best work and be ready and willing to serve as reviewers. More than anything else, this will be a true test of the commitment of members of this community to the success of this journal. As a member of both pigment cell and melanoma societies, I commit to continue to do my part.

担任《色素细胞与黑色素瘤研究》杂志的主编是我的荣幸。这在许多方面都是一本独特的期刊。它是两个科学协会的官方期刊。最初是在色素细胞学会联合会的支持下成立的色素细胞研究中心，后来通过欢迎黑色素瘤研究学会成为平等合作伙伴而成为色素细胞和黑色素瘤研究中心。通过这次合并，现在发表的手稿范围涵盖了最广泛的主题，包括黑色素化学、脊椎动物色素沉着、色素疾病、黑色素瘤生物学和临床试验。我喜欢在前排欣赏这片广阔的风景，并尽一切努力使每一期都能反映期刊的范围。

我要感谢很多人，他们让我的旅程变得有价值。首先是副主编，他们经常承担同等的负担；同事，每次被要求审阅稿件时都会挺身而出；以及 Wiley 的期刊工作人员，他们为工作流程提供支持。我将错过成为第一个目睹世界各地实验室研究成果的机会和荣幸。我将错过阅读我所推崇的研究人员富有洞察力的评论的机会。

六年前，当我接受担任该期刊的主编时，在快速变化的期刊出版格局中，对该期刊当前形式的生存能力存在一些不言而喻的怀疑。作为一个乐观主义者，我对这种怀疑不予理睬。即使在战壕里奋斗了 6 年，包括 COVID-19 大流行的困难时期，我仍然对这本独特期刊的未来持乐观态度。现在并且将会有许多挑战需要克服。期刊的好坏取决于它收到的稿件的质量以及这些稿件的同行评审。因此，我真诚地希望色素细胞和黑色素瘤界的成员，因为我们对这个被称为“黑色素细胞”的迷人实体的兴趣而团结在一起，选择该期刊作为他们提交和发表他们最好的作品的首选，并做好准备并愿意担任审稿人。最重要的是，这将是对该社区成员对该期刊成功的承诺的真正考验。作为色素细胞协会和黑色素瘤协会的成员，我承诺继续尽自己的一份力量。